Aerosol time-of-flight mass spectrometry (ATOFMS) measurements provide continuous information on the aerodynamic size and chemical composition of individual particles. In this work, we compare two approaches for converting unscaled ATOFMS measurements into quantitative particle mass concentrations using (1) reference mass concentrations from a co-located micro-orifice uniform deposit impactor (MOUDI) with an accurate estimate of instrument busy time and (2) reference number concentrations from a co-located aerodynamic particle sizer (APS). Aerodynamic-diameter-dependent scaling factors are used for both methods to account for particle transmission efficiencies through the ATOFMS inlet. Scaling with APS data retains the high-resolution characteristics of the ambient aerosol because the scaling functions are specific for each hourly time period and account for a maximum in the ATOFMS transmission efficiency curve for larger-sized particles. Scaled mass concentrations obtained from both methods are compared with co-located PM(2.5) measurements for evaluation purposes. When compared against mass concentrations from a beta attenuation monitor (BAM), the MOUDI-scaled ATOFMS mass concentrations show correlations of 0.79 at Fresno, and the APS-scaled results show correlations of 0.91 at Angiola. Applying composition-dependent density corrections leads to a slope of nearly 1 with 0 intercept between the APS-scaled absolute mass concentration values and BAM mass measurements. This paper provides details on the methodologies used to convert ATOFMS data into continuous, quantitative, and size-resolved mass concentrations that will ultimately be used to provide a quantitative estimate of the number and mass concentrations of particles from different sources.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac060395qDOI Listing

Publication Analysis

Top Keywords

mass concentrations
32
mass
12
concentrations
9
aerosol time-of-flight
8
time-of-flight mass
8
mass spectrometry
8
atofms measurements
8
concentrations co-located
8
atofms
6
measurements
5

Similar Publications

Background: Recently, environmental pollution has become a significant concern for human, animal, and environmental health, fitting within the "One Health" framework. Among the various environmental contaminants, per- and polyfluoroalkyl substances (PFASs) have gathered substantial attention due to their persistence, bioaccumulation, and adverse health effects. This study aimed to compare the levels of 12 PFASs in the fur, liver, and muscle of wild roe deer to evaluate the feasibility of using fur as a non-invasive biomonitoring matrix.

View Article and Find Full Text PDF

Comprehensive global proteome profiling that is amenable to high throughput processing will broaden our understanding of complex biological systems. Here, we evaluated two leading mass spectrometry techniques, Data Independent Acquisition (DIA) and Tandem Mass Tagging (TMT), for extensive protein abundance profiling. DIA provides label-free quantification with a broad dynamic range, while TMT enables multiplexed analysis using isobaric tags for efficient cross-sample comparisons.

View Article and Find Full Text PDF

High Molecular-Weight Organics as Precursors for Toxic Iodinated Disinfection Byproducts during Chloramination.

Environ Sci Technol

January 2025

State Key Laboratory of Pollution Control and Resources Reuse, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.

Iodinated DBPs (I-DBPs), many more toxic than regulated chlorinated and/or brominated DBPs, are a major challenge in the supply of safe drinking water. While over 800 DBPs have been identified, the occurrence and precursors of toxic I-DBPs remain poorly understood. Herein, natural organic matter from two raw drinking waters was fractionated using ultrafiltration membranes into different groups based on molecular weight (MW).

View Article and Find Full Text PDF

In recent times, a truly exquisite pharmaceutical marvel has graced the world of medicine, known as Safinamide (SAF). This opulent creation has been specifically tailored to cater to the needs of individuals afflicted with Parkinson's disease (PD), an esteemed neurological condition renowned for its regal ability to impede motor skills, coordination, and equilibrium. It is highly improbable that degradation products of pharmaceutical components would significantly compromise efficiency and safety of a drug during its shelf life.

View Article and Find Full Text PDF

Background: Nivolumab is an immune checkpoint inhibitor (ICI) that selectively inhibits programmed cell death protein 1 activation, restoring antitumor immunity. ICIs are indicated for various types of advanced solid tumors; however, not all patients benefit from them, and tools that could be used in the clinic to predict response to treatment represent an unmet need. Here we describe the development of a new population pharmacokinetic (PPK) model in patients treated with nivolumab in clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!